Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Olympus ProMarketing: Periodontal Disease Prevention Tool PerioMicro
August 5, 2002
- Fujisawa Ties Up with MerLion of Singapore for Enzyme Research
August 5, 2002
- Hitachi Medical to Gear Up New Business, Overseas Marketing
August 5, 2002
- Wholesalers Must Finish Price Negotiations by Mid-year Settlement of Accounts: Mr Matsutani
August 5, 2002
- Bayer Medical: Multistix Urinalysis Strips for Renal Disease Detection
August 5, 2002
- Price Agreement Rates Are Slightly Better Than in 2000: Azwell
August 5, 2002
- Kyowa Medex to Exclusively Market NID Diagnostic Products
August 5, 2002
- BUSINESS NEWS IN BRIEF
August 5, 2002
- WORLD NEWS IN BRIEF
August 5, 2002
- Website News
August 5, 2002
- BUSINESS BULLETIN
August 5, 2002
- CORPORATE ROUNDUP NEWS IN BRIEF
August 5, 2002
- REGULAROTY BULLETIN
August 5, 2002
- stay.safe balance to Enhance QOL of Dialysis Patients: Mr van Hest of Fresenius
August 5, 2002
- NEW PRODUCTS
August 5, 2002
- Sankyo to Tie Up with LifeSpan Biosciences on Pharmacogenomics
August 5, 2002
- Dainippon Licenses Reagent to Determine Blood Zonisamide to Opus of the US
August 5, 2002
- Molecular Targeted Drugs for Liver Cancer: Banyu, IMSUT
August 5, 2002
- Wholesalers May Be Engaged in Disease Management: Mr Bessho of Suzuken
August 5, 2002
- Aderans to Start Research on Hair Regeneration Therapy in US
August 5, 2002
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…